Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 27th July 2015
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Eurostars backs development of canine cancer drug
Dig lysung down
The drug will be an important contribution to the improvement of cancer treatment in dogs.

Antivascular treatment to receive £1.4m of funding
 
The development of a new antivascular drug to fight cancer in dogs is to receive £1.4m in funding from Eurostars.

French-based pharmaceutical company Ecrins Therapeutics has teamed-up with Dr Barbara Kaser-Hotz from Switzerland's Animal Oncology and Imaging Centre (AOIC) and Dr Susan North from the UK's leading private Small Animal Cancer Treatment Centre (VRCC) to test and develop this new and exciting treatment option.

The company has already invested over two million euros in the development of the treatment and Eurostar's contribution will add a further 1.6 million euros (£1.4m) to the pot.  The project began in April 2015 and it is hoped that the drug will come to market in the few years.

Eurostars is an organisation which supports international innovative projects led by research and development-performing small and medium sized enterprises. With its forward-thinking approach, the organisation supports the development of rapidly marketable innovative products, processes and services that help improve the daily lives of people around the world.

Ecrins Therapeutics, AOIC and VRCC came 19th out of 323 Eurostars eligible applications. They are all now looking forward to working together and playing an important contribution to the improvement of cancer treatment in dogs.

Become a member or log in to add this story to your CPD history

VMD invites students to apply for EMS placement

News Story 1
 The Veterinary Medicines Directorate (VMD) is inviting applications from veterinary students to attend a one-week extramural studies (EMS) placement in July 2026.

Students in their clinical years of study have until 28 February to apply for the placement, which takes place at the VMD's offices in Addlestone, Surrey, from 6-10 July 2026.

Through a mixture of lectures and workshops, the placement will explore how veterinary medicines are authorised, non-clinical career opportunities, and other important aspects of the VMD's work.  

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk